Leonardo DRS, Inc.: Form 10-Q for the period ended Sep 30, 2021
Filed with the SEC on Nov 12, 2021 and accepted by EDGAR at Nov 12, 2021, 10:43 ET.
Management's discussion and analysis
As filed, 66,205 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
You should read this discussion together with our consolidated financial statements and related notes thereto included elsewhere in this Quarterly Report.
This discussion and other parts of this Quarterly Report include forward-looking statements such as those relating to our plans, objectives, expectations and beliefs, which involve risks, uncertainties and assumptions. These forward-looking statements are subject to numerous risks and uncertainties, including, but not limited to, the risks and uncertainties discussed under “Special Note Regarding Forward-Looking Statements and Information” in this Quarterly Report and under “Risk Factors” in our registration statement on Form S-1, as amended (Registration No. 333-253583), which was declared effective by the SEC on March 23, 2021. Actual results may differ materially from those contained in any forward-looking statements.
Business Overview and Considerations
General
We are a leading provider of defense products and technologies that are used across land, air, sea, space and cyber domains. Our diverse array of defense systems and solutions is offered to all branches of the U.S. military, major aerospace and defense prime contractors, government intelligence agencies and international military customers for deployment on a wide range of military platforms. We focus our capabilities in areas of critical importance to the U.S. military within three segments, Advanced Sensor Technologies, Network Computing & Communications and Integrated Mission Systems. Our revenue, earnings and cash flows are generated by a combination of developing, manufacturing and servicing advanced technology solutions that are designed to address mission critical challenges for the defense industry.
Our overall strategy is to be a balanced and diversified company, less vulnerable to any one budgetary platform or service decision with a specific focus on establishing strong technical and market positions in areas of priority for the U.S. Department of Defense (“DoD”). The DoD is our largest customer. For the third quarter and first nine months of 2021, the DoD accounted for approximately 84% and 85%, respectively, of our business as an end-user. The revenues for the three- and nine-month periods ended September 30, 2021 are principally derived directly or indirectly from contracts with the U.S. Army, which represented 33% and 36%, respectively, and the U.S. Navy, which represented 31% and 31%, respectively, of our consolidated revenue, in each case consistent with historic trends.
Our operations and reporting are structured into the following three technology driven segments based on the capabilities and solutions offered to our customers:
Advanced Sensor Technologies (“AST”): Our Advanced Sensor Technologies segment provides world-class electro-optical sensor technologies, laser systems, EW systems and intelligence and surveillance solutions to U.S. military and intelligence community customers. We are a leading provider of ground vehicle targeting and surveillance sensors, including electro-optical and advanced detection systems. We are also a leading provider of soldier sensor systems in high priority modernization areas such as infrared imaging and precision targeting systems. Our infrared focal plane array foundry is recognized as a leading provider of high performance and small sized cryogenically cooled and uncooled detector arrays. We are also a leading and world-recognized provider of aircraft training instrumentation equipment and high-performance radio frequency receivers and transceivers for U.S. and international customers. Our quantum cascade laser technology has promising military and commercial medical applications. Collectively, these sensor technologies provide our warfighters with a distinct battlefield advantage.
Network Computing & Communications (“NC&C”): Our Network Computing & Communications segment provides advanced defense electronics solutions across warfare domains. Our technologies and products are used on legacy and new military platforms and include end-to-end network communication systems, network services and cyber solutions. We are a leading provider of ruggedized computing equipment, having provided advanced tactical computing units for ground combat vehicles and command post operations for more than two decades. We also provide the U.S. Navy and its allies, we provide naval computing infrastructure, network and data distribution, radar and rugged naval control systems, which are present on naval surface and subsurface combatant vessels. Across the full spectrum of our network computing capabilities, we have leadership positions at both the product and sub-systems levels. Our global communications network is a worldwide network of terrestrial and satellite bandwidth that ensures our customers’ data is secure and reliable. As a result of this capability, we are positioned as one of the leading providers of secured satellite communications to the U.S. military.
Integrated Mission Systems (“IMS”): Our Integrated Mission Systems segment provides critical force protection, vehicle integration, transportation and logistics and electrical conversion and ship propulsion systems to the U.S. military. Our force protection systems provide much needed protection for our service members and military assets from evolving threats and include advanced solutions for counter-unmanned aerial systems, short-range air defense systems and active protection systems on ground vehicles. We have military transportation and logistics offerings and ground vehicle integration capabilities to support U.S. forces in a wide range of operational environments. Additionally, we provide power conversion and propulsion systems for the U.S. Navy’s top priority shipbuilding programs, building on our legacy of providing power components and systems for nearly all naval combat vessels for three decades, positioning us to continue as a leading provider of electrical ship propulsion systems and components for the U.S. Navy.
Focus on Customer and Execution
DRS and its employees focus on our end-customers – the men and women of the armed forces in the U.S. and its allies. We seek to provide high-quality equipment and services to support their mission success. We strive for excellence in everything we do, in every job in our Company, in order to satisfy our customers’ needs embedded in our contractual commitments. We seek to ensure that we learn from every lesson experienced in our Company and insist that these lessons affect all elements of our businesses. This approach permeates through the Company with a focus on continuous improvement at every level.
Part of this learning has resulted in institutionalizing our continuous improvement process through our Operational Excellence initiative called “Always Performing For Excellence,” or “APEX,” program. The APEX program’s goal is to strive for continuous improvement through unification of our business practices, tools and metrics, ongoing employee training and innovation. We believe that excellence is not a destination, but by constantly challenging ourselves to be better, we will improve, and ultimately approach excellence. We challenge ourselves to exceed our customers’ expectations and we partner with them to work to ensure that our execution meets their needs.
Continuous improvement, through the APEX program also allows us to improve our efficiency, which contributes to increased margins, helps us to remain competitive and allows us to make strategic investments, all while maintaining our focus on customer satisfaction. In these elements, our goals are aligned with those of our customers. We are humbled by the dedication and sacrifice that our ultimate customers have made to serve and we work to perform for them with excellence in everything we do.
Impacts of COVID-19 On Our Business
We are continuing to closely monitor COVID-related impacts on all aspects of our business and geographies, including on our workforce, supply chain and customers. On September 9, 2021, President Biden announced a COVID-19 action plan, including an executive order, the Safer Workforce Task Force guidance issued on September 24, 2021 and the DoD’s Force Health Protection guidance. This executive order and guidance (as amended) requires U.S. based federal contractors’ employees to have had their final vaccination dose by January 4, 2022, with exceptions including where an employee is legally entitled to an accommodation. We are taking steps to comply with the executive order, guidance and related contractual terms required by our customers. The Occupations Safety and Health Administration has announced that it is developing an emergency temporary standard for employers with 100 or more employees to ensure their workers are fully vaccinated or undergo weekly testing. State and local governments are also continuing to take actions related to the pandemic, imposing additional and varying requirements on our industry. We are continuing to evaluate these evolving requirements, especially as our customers determine when and how to implement new contractual requirements. We cannot at this stage predict the various impacts they may have on our workforce, our suppliers, or our company. These evolving government requirements, including regarding a vaccine mandate, along with broader impacts of the continuing pandemic, could impact our workforce and performance, as well as those of our suppliers.
DRS remains committed to the safety, health, and well-being of our employees while ensuring the continuity of our operations. We do this by adhering to our three primary goals: keeping our employees and their families safe; mitigating risk associated with interruption of suppliers’ materials; and maintaining our commitment to our customers. Where necessary we continue to maintain physical separation of the essential employees into smaller work zones and quarantining of a zone when there is a concern of potential exposure. Our health and safety protocols continue with intra-shift sanitization at each facility, providing PPE to employees, and ensuring employees stay home when not feeling well or when potentially exposed. For non-essential workers we continue to fully support teleworking. With the release of the COVID-19 vaccines, we have held vaccine clinics at our major facilities to provide easy access for our employees and have created a vaccine incentive program for them to earn an incentive award when fully vaccinated and allowing them elect to receive the award or donate the award to the American Red Cross.
We continue to review our mitigation efforts to respond to the changing COVID-19 environment, and are engaged in planning and adapting to a future workforce for when the infection rates diminish. As reported for 2020, we incurred $12 million of expenditures to include paid leave, personal protective equipment and other cleaning measures, facility filtration systems and social and physical distancing efforts. From January 1, 2021 through September 30, 2021, we have incurred an additional $6 million of expenditures related to ensuring a safe work environment for our employees.
Business Environment
Revenues derived directly, as a prime contractor, or indirectly, as a subcontractor, from contracts with the U.S. government represented 84% and 85% of our consolidated revenue for the third quarter and first nine months of 2021, respectively, and 83% of our consolidated revenue for the third quarter and first nine months of 2020. Of these sales directly to the U.S. government, the Army and Navy are our largest customers. For the three- and nine-month periods ended September 30, 2021, U.S. government sales with the U.S. Army represented 33% and 36% and U.S. government sales with the U.S. Navy represented 31% and 31%, respectively, of our consolidated revenue. For the three- and nine-month periods ended September 30, 2020, U.S. government sales with the U.S. Army represented 31% and 38% and U.S. government sales with the U.S. Navy represented 28% and 33%, respectively, of our consolidated revenue.
The President’s Fiscal Year 2022 (“FY22”) budget request is still pending before Congress. Congressional defense committees have advanced various versions of authorization and appropriations bills, which are to be finalized before submittal to the President for signature into law.
The House Defense Appropriations Subcommittee recommended funding of $705.9 billion, about $10 billion more than last year’s funding level. The committee recommended $134.3 billion in base procurement funding, an increase of $1.7 billion above the FY22 budget request. The additional procurement funding would be allocated towards ground vehicles, aircraft, ships, munitions, and other equipment. The committee recommended $110.4 billion in research, development, test and evaluation (“RDT&E”) funding, which was $1.6 billion below the FY22 budget request, but above last year’s enacted level.
In July, the Senate Armed Services Committee approved its version of the FY22 National Defense Authorization Act (“NDAA”). The committee recommended adding an additional $25 billion over the President’s FY22 budget request, significantly increasing the authorized budget from $715 billion to $740 billion.
In September, the House Armed Services Committee approved its version of the NDAA. The committee recommended adding $23.9 billion to the overall FY22 budget request, which would increase the overall budget to $740 billion, in line with the Senate Armed Services Committee recommendation. On September 23, 2021, the House of Representatives approved the NDAA, setting it up for a conference with the Senate.
In October, the Senate Defense Appropriations Subcommittee recommended adding approximately $24 billion to the President’s FY22 budget request, which included significant procurement increases and additional RDT&E funding.
The FY22 budget request and committee recommendations address the global challenges the U.S. military faces, including competition with China and Russia. We believe these policy and funding priorities align well with our focused markets and investments, including in areas such as sensing, network communications, electronic warfare, force protection, and power and propulsion.
Key Financial and Operating Measures
Overview
We measure our business using both key financial and operating data including key performance indicators (“KPIs”) and non-GAAP financial measures and use the following metrics to manage our business, monitor results of operations and ensure proper allocation of capital: (i) Revenue, (ii) Bookings, (iii) Backlog, (iv) Adjusted EBITDA, (v) Adjusted EBITDA Margin, (vi) Adjusted Earnings Per Share (“EPS”) and (vii) Free Cash Flow. We believe that these financial performance metrics represent the primary drivers of value enhancement, balancing both short and long-term indicators of increased shareholder value. These are the metrics we use to measure our results and evaluate our business and related contract performance. See “—Results from Operations” for further detail.
Financial and Operating Data
(Dollars in millions, except per share amounts)
| Three Months Ended September 30, 2021 | 2020 | Nine Months Ended September 30, 2021 | 2020 | |
|---|---|---|---|---|
| Total revenues | $720 | $719 | $2,059 | $1,952 |
| Bookings | 484 | 950 | 1,919 | 2,542 |
| Backlog | 3,152 | 3,454 | 3,152 | 3,454 |
| Adjusted EBITDA(1) | 71 | 61 | 210 | 156 |
| Adjusted EBITDA Margin(1) | 9.8% | 8.5% | 10.2% | 8.0% |
| Adjusted EPS(1)(2) | $0.25 | $0.17 | $0.73 | $0.34 |
| Free Cash Flow(1) | $109 | $42 | $(153) | $(267) |
(1) Note on non-GAAP financial measures: Throughout the discussion of our results of operations we use non-GAAP financial measures including Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted EPS and Free Cash Flow, as measures of our overall performance. Definitions and reconciliations of these measures to the most directly comparable financial measure calculated and presented in accordance with U.S. GAAP are included below.
(2) Gives effect to a 1,450,000-for-1 forward stock split on our common stock effected on February 25, 2021.
Bookings - We define bookings as the total value of contract awards received from the U.S. government for which it has appropriated funds and legally obligated such funds to the Company through a contract or purchase order, plus the value of contract awards and orders received from customers other than the U.S. government.
Backlog - We define Backlog to include the following components:
(1) Funded - Funded backlog represents the revenue value of orders for services under existing contracts for which funding is appropriated or otherwise authorized less revenue previously recognized on these contracts.
(2) Unfunded - Unfunded backlog represents the revenue value of firm orders for products and services under existing contracts for which funding has not yet been appropriated less funding previously recognized on these contracts.
The unfunded and funded backlog combine to equal the total backlog as depicted in the table below at the respective date presented:
(Dollars in millions)
| Backlog: | September 30, 2021 |
|---|---|
| Total Backlog | $3,152 |
Non-GAAP Financial Measures
We believe the non-GAAP financial measures presented in this Quarterly Report will help investors understand our financial condition and operating results and assess our future prospects. We believe these non-GAAP financial measures, each of which is discussed in greater detail below, are important supplemental measures because they exclude unusual or non-recurring items as well as non-cash items that are unrelated to or may not be indicative of our ongoing operating results. Further, when read in conjunction with our U.S. GAAP results, these non-GAAP financial measures provide a baseline for analyzing trends in our underlying businesses and can be used by management as a tool to help make financial, operational and planning decisions. Finally, these measures are often used by analysts and other interested parties to evaluate companies in our industry by providing more comparable measures that are less affected by factors such as capital structure.
We recognize that these non-GAAP financial measures have limitations, including that they may be calculated differently by other companies or may be used under different circumstances or for different purposes, thereby affecting their comparability from company to company. In order to compensate for these and the other limitations discussed below, management does not consider these measures in isolation from or as alternatives to the comparable financial measures determined in accordance with U.S. GAAP. Readers should review the reconciliations below and should not rely on any single financial measure to evaluate our business.
We define these non-GAAP financial measures as:
Adjusted EBITDA and Adjusted EBITDA Margin - We define Adjusted EBITDA as our net earnings before income taxes, amortization of acquired intangible assets, depreciation, restructuring costs, interest, transaction costs related to an anticipated offering of securities, acquisition and divestiture related expenses, foreign exchange, COVID-19 response costs, non-service pension expenditures and other one-time non-operational events. Adjusted EBITDA Margin is calculated by dividing Adjusted EBITDA by revenue. Adjusted EBITDA and Adjusted EBITDA Margin are not measures calculated in accordance with U.S. GAAP, and they should not be considered an alternative to any financial measures that were calculated under U.S. GAAP. Adjusted EBITDA and Adjusted EBITDA Margin are used to facilitate a comparison of the ordinary, ongoing and customary course of our operations on a consistent basis from period to period and provide an additional understanding of factors and trends affecting our business. Adjusted EBITDA and Adjusted EBITDA Margin are driven by changes in volume, performance, contract mix and general and administrative expenses and investment levels. Performance, as used in this definition, refers to changes in profitability and is primarily based on adjustments to estimates at completion on individual contracts. These adjustments result from increases or decreases to the estimated value of the contract, the estimated costs to complete the contract, or both. These measures therefore assist management and our board and may be useful to investors in comparing our operating performance consistently over time as they remove the impact of our capital structure, asset base and items outside the control of the management team and expenses that do not relate to our core operations. Adjusted EBITDA and Adjusted EBITDA Margin may not be comparable to similarly titled non-GAAP measures used by other companies as other companies may have calculated the measures differently. The reconciliation of Adjusted EBITDA to net earnings (loss) is provided below:
Consolidated Entity Adjusted EBITDA Reconciliation:
(Dollars in millions)
| Three Months Ended September 30, 2021 | 2020 | Nine Months Ended September 30, 2021 | 2020 | |
|---|---|---|---|---|
| Net earnings (loss) | $35 | $15 | $96 | $38 |
| Income tax provision (benefit) | $8 | $4 | $31 | $11 |
| Amortization of intangibles | $3 | $3 | $7 | $7 |
| Depreciation | 13 | 11 | 37 | 33 |
| Restructuring costs | 1 | 2 | 1 | 4 |
| Interest expense | 9 | 17 | 27 | 49 |
| Transaction costs related to an anticipated offering of securities | — | — | 4 | — |
| Foreign exchange | — | (1) | 1 | (1) |
| COVID-19 response costs | 1 | 9 | 6 | 11 |
| Non-service pension expense | — | — | — | 2 |
| Other one-time non-operational events | — | 2 | — | 3 |
| Adjusted EBITDA | $71 | $61 | $210 | $156 |
Adjusted EPS – We calculate Adjusted EPS by excluding transaction costs related to an anticipated offering of securities, acquisition and divestiture related expenses and COVID-19 response costs from our net earnings (loss) to arrive at Adjusted EPS. We believe that Adjusted EPS allows investors to effectively compare our core performance from period to period by excluding items that are not indicative of, or are unrelated to, results from our ongoing business operations such as our capital structure, significant non-cash expenses, the impacts of financing decisions on earnings, and items incurred outside the ordinary, ongoing and customary course of our business. Adjusted EPS has limitations as an analytical tool and does not represent, and should not be considered an alternative to basic or diluted EPS as determined in accordance with U.S. GAAP. The reconciliation of Adjusted EPS to U.S. GAAP EPS is shown below:
Consolidated Entity Reconciliation of Adjusted EPS:
(Dollars in millions, except per share amounts)
| Three Months Ended September 30, 2021 | 2020 | Nine Months Ended September 30, 2021 | 2020 | |
|---|---|---|---|---|
| Net earnings (loss) | $35 | $15 | $96 | $38 |
| Transaction costs related to an anticipated offering of securities | $— | $— | $4 | $— |
| COVID-19 response costs | $1 | $9 | $6 | $11 |
| Adjusted net earnings (loss) | $36 | $24 | $106 | $49 |
| Adjusted EPS (1) | $0.25 | $0.17 | $0.73 | $0.34 |
(1) Gives effect to a 1,450,000-for-1 forward stock split on our common stock effected on February 25, 2021.
Free Cash Flow – We define free cash flow as the sum of the cash flows provided by operating activities and the cash flows provided by (used in) investment activities pertaining to capital expenditures and proceeds generated from the sale of capital assets.
We believe that free cash flow provides management and investors with an important measure of our ability to generate cash on a normalized basis. Free cash flow also provides insight into our flexibility to allocate capital and pursue opportunities that may enhance shareholder value. We believe that while expenditures and dispositions of property plant and equipment will fluctuate period to period, we seek to ensure that we have adequate capital on hand to maintain ongoing operations and enable growth of the business. Additionally, free cash flow is of limited usefulness, in that it does not represent residual cash flows available for discretionary expenditures, due to the fact the measures do not deduct the payments required for debt service and other contractual obligations or payments. The reconciliation between free cash flow and net cash provided by operating activities (the most comparable U.S. GAAP measure) is shown below:
Consolidated Entity Reconciliation of Free Cash Flow:
(Dollars in millions)
| Three Months Ended September 30, 2021 | 2020 | Nine Months Ended September 30, 2021 | 2020 | |
|---|---|---|---|---|
| Net Cash provided by (used in) operating activities | $138 | $66 | $(111) | $(230) |
| Capital expenditures | (29) | (24) | (42) | (37) |
| Proceeds from sales of assets | — | — | — | — |
| Free cash flow | $109 | $42 | $(153) | $(267) |
Factors Impacting Our Performance
U.S. Government Spending and Federal Budget Uncertainty
Changes in the volume and relative mix of U.S. government spending as well as areas of spending growth could impact our business and results of operations. In particular, our results can be affected by shifts in strategies and priorities on homeland security, intelligence, defense-related programs, infrastructure and urbanization and continued increased spending on technology and innovation, including cybersecurity, artificial intelligence, connected communities and physical infrastructure. Cost-cutting and efficiency initiatives, current and future budget restrictions, spending cuts and other efforts to reduce government spending and shifts in overall priorities (for example, in response to the COVID-19 pandemic or related government mandates to contain and reduce its spread) could cause our government customers to reduce or delay funding or invest appropriated funds on a less consistent basis or not at all, and demand for our solutions or services could diminish. Furthermore, any disruption in the functioning of government agencies, including as a result of government closures and shutdowns, could have a negative impact on our operations and cause us to lose revenue or incur additional costs due to, among other things, our inability to maintain access and schedules for government testing or deploy our staff to customer locations or facilities as a result of such disruptions.
There is also uncertainty around the timing, extent, nature and effect of Congressional and other U.S. government actions to address budgetary constraints, caps on the discretionary budget for defense and non-defense departments and agencies, and the ability of Congress to determine how to allocate the available budget authority and pass appropriations bills to fund both U.S. government departments and agencies that are, and those that are not, subject to the caps. Additionally, budget deficits and the growing U.S. national debt, including as a result of legislative actions in response to the COVID-19 pandemic, may increase pressure on the U.S. government to reduce federal spending across all federal agencies, with uncertainty about the size and timing of those reductions. Furthermore, delays in the completion of future U.S. government budgets could in the future delay procurement of the federal government services we provide. A reduction in the amount of, or reductions, delays, or cancellations of funding for, services that we are contracted to provide to the U.S. government as a result of any of these impacts or related initiatives, legislation or otherwise could have a material adverse effect on our business and results of operations.
Operational Performance on Contracts
Revenue, earnings (margin) and the timing of our cash flows depend on our ability to perform on our contracts. When agreeing to contractual terms, our management team makes assumptions and projections about future conditions and events. The accounting for our contracts and programs requires assumptions and estimates about these conditions and events. These projections and estimates assess:
- the productivity and availability of labor;
- the allocation of indirect costs to labor and material costs incurred
- the complexity of the work to be performed;
- the cost and availability of materials and components; and
- schedule requirements.
If there is a significant change in one or more of these circumstances, estimates or assumptions, or if the risks under our contracts are not managed adequately, the profitability of contracts could be adversely affected. This could affect earnings and margin materially.
In particular, profitability can fluctuate predicated on the type of contract awarded. Typically fixed-price development programs on complex systems represent a higher risk profile to complete on-budget. To the extent our fixed-price development efforts create a larger portion of our revenue output, this may result in reduced operating margins given the higher risk profile. The following represents the impact that changing certain of our estimates, particularly those regarding our fixed-price development programs, would have had have on our revenues:
Impact of Change in Estimates on our Revenue Results
(Dollars in millions)
| Three Months Ended September 30, 2021 | 2020 | Nine Months Ended September 30, 2021 | 2020 | |
|---|---|---|---|---|
| Revenue | $(11) | $(30) | $(20) | $(63) |
| Total % of Revenue | 1.6% | 4.2% | 1.0% | 3.2% |
Additionally, the timing of our cash flows is impacted by the timing of achievement of billable milestones on contracts. Historically, this has resulted and could continue to result in fluctuations in working capital levels and quarterly free cash flow results. As a result of such quarterly fluctuations in free cash flow results, we believe that quarter-to-quarter comparisons of our results of operations may not necessarily be meaningful and should not be relied upon as indicators of future performance.
Regulations
Increased audit, review, investigation and general scrutiny by U.S. government agencies of performance under government contracts and compliance with the terms of those contracts and applicable laws could affect our operating results. Negative publicity and increased scrutiny of government contractors in general, including us, relating to government expenditures for contractor services and incidents involving the mishandling of sensitive or classified information as well as the increasingly complex requirements of the DoD and the United States intelligence community, including those related to cybersecurity, could impact our ability to perform in the markets we serve.
International & Commercial Sales
International revenue, including foreign military sales, foreign military financing, and direct commercial sales, accounted for approximately 15% of our revenue for the three and nine months ended September 30, 2021 which is consistent with prior year trends. Since our focus is primarily with the DoD and our investments are focused as such, we anticipate that international sales will continue to account for a similar percentage of revenue in the future. We remain subject to the spending levels, pace and priorities of the U.S. government as well as international governments and commercial customers, and to general economic conditions that could adversely affect us, our customers and our suppliers.
Additionally, some international sales may expose us to foreign exchange fluctuations and changing dynamics of foreign competitiveness based on variations in the value of the U.S. dollar relative to other currencies. The impact of those fluctuations is reflected throughout our Consolidated Financial Statements, but in the aggregate, did not have a material impact on our results of operations for three- and nine-month periods ended September 30, 2021.
Acquisitions
We consider the acquisition of businesses and investments that we believe will expand or complement our current portfolio and allow access to new customers or technologies. We also may explore the divestiture of businesses that no longer meet our needs or strategy or that could perform better outside of our organization.
Components of Operations
Revenue
Revenue consists primarily of product related revenue, generating 84% of our total revenues for the third quarter and first nine months of 2021. Our remaining revenue is generated from service related contracts. Additionally, 86% of our revenue is derived from firm-fixed priced contracts for both the three- and nine-month periods ended September 30, 2021. This is consistent for both contract types when compared to product sales and firm-fixed priced sales of 84% and 86% ,respectively, for the three and nine months ended September 30, 2020.
Under flexibly priced contracts, we are reimbursed for allowable or otherwise defined total costs (defined as cost of revenues plus allowable general and administrative expenses) incurred, plus a fee. The contracts may also include incentives for various performance criteria, including quality, timeliness, cost-effectiveness or other factors. For the third quarter and first nine months of 2021 flexible priced contracts represented 14% of our total revenues.
Please refer to Note 1. Summary of Significant Accounting Policies and Note 2. Revenue from Contracts with Customers in the Notes to our Consolidated Financial Statements.
Cost of Revenues
Cost of revenues includes materials, labor and overhead costs incurred in the manufacturing, design, and provision of products and services sold in the period as well as warranty costs. Material costs include raw materials, purchased components and sub-assemblies and outside processing and inbound freight. Labor and overhead costs consist of direct and indirect manufacturing costs, including wages and fringe benefits, operating supplies, depreciation and amortization, occupancy costs, and purchasing, receiving, inspection costs and inbound freight costs.
General and Administrative Expenses
General and administrative expenses include general and administrative expenses not included within cost of revenues such as salaries, wages and fringe benefits, facility costs and other costs related to these indirect functions. Additionally, general and administrative expenses include internal research and development costs as well as expenditures related to bid and proposal efforts. We expect general and administrative expenses will be impacted by the costs associated with being a publicly-traded company.
Results from Operations
The following discussion of operating results is intended to help the reader understand the results of operations and financial condition of the Company, as well as individual segments, for the third quarter and first nine months of 2021, as compared to the third quarter and first nine months of 2020. Given the nature of our business, we believe revenue and earnings from operations are most relevant to an understanding of our performance at a business and segment level. Our operating cycle is lengthy and involves various types of production contracts and varying delivery schedules. Accordingly, operating results in a particular year may not be indicative of future operating results.
(Dollars in millions, except per share amounts)
| Three Months Ended September 30, 2021 | Three Months Ended September 30, 2020 | September 30, 2021 vs. September 30, ,2020 Variance $% | ||
|---|---|---|---|---|
| Total revenues | $720 | $719 | $1 | 0.1% |
| Total cost of revenues | (589) | (597) | $8 | (1.4)% |
| Gross profit | $131 | $122 | $9 | 7.3% |
| Gross margin | 18.2% | 16.9% | 1.2% | 7.2% |
| General and administrative expenses | (73) | (72) | $(1) | 1.4% |
| Amortization of intangibles | (3) | (3) | $— | 7.1% |
| Other operating expenses, net | (2) | (10) | $8 | (80.0)% |
| Operating earnings | $53 | $37 | $16 | 42.4% |
| Interest expense | $(9) | $(17) | $8 | (47.1)% |
| Other, net | $(1) | $(1) | $— | —% |
| Earnings before taxes | $43 | $19 | $24 | 124.7% |
| Income tax provision | $8 | $4 | $4 | 100.0% |
| Net earnings | $35 | $15 | $20 | 131.3% |
| Shares outstanding(1) | 145 | 145 | $— | —% |
| Basic EPS(1) | $0.24 | $0.10 | $0.14 | 131.3% |
| Diluted EPS(1) | $0.24 | $0.10 | $0.14 | 131.3% |
| Adjusted EPS(1,2) | $0.25 | $0.17 | $0.08 | 48.0% |
| Adjusted EBITDA(2) | $71 | $61 | $9 | 15.0% |
| Adjusted EBITDA Margin(2) | 9.8% | 8.5% | 1.3% | 14.9% |
| Backlog(2) | $3,152 | $3,454 | $(303) | (8.8%) |
| Bookings(2) | $484 | $950 | $(467) | (49.1)% |
| Free cash flow(2) | $109 | $42 | $67 | 158.8% |
NM- percentage change not meaningful
(1) Gives effect to a 1,450,000-for-1 forward stock split on our common stock effected on February 25, 2021.
(2) See “—Non-GAAP Financial Measures” above for definitions of these measures. Adjusted EPS, Adjusted EBITDA, Adjusted EBITDA Margin and free cash flow are non-GAAP measures. See “—Key Financial and Operating Measures—Non-GAAP Financial Measures” above for reconciliations of these measures to the most directly comparable financial measure calculated and presented in accordance with U.S. GAAP.
(Dollars in millions, except per share amounts)
| Nine Months Ended September 30, 2021 | Nine Months Ended September 30, 2020 | September 30, 2021 vs. September 30, ,2020 Variance $% | ||
|---|---|---|---|---|
| Total revenues | $2,059 | $1,952 | $107 | 5.5% |
| Total cost of revenues | (1,665) | (1,615) | $(50) | 3.1% |
| Gross profit | $394 | $337 | $57 | 16.9% |
| Gross margin | 19.1% | 17.3% | 1.9% | 10.8% |
| General and administrative expenses | (225) | (214) | $(11) | 5.1% |
| Amortization of intangibles | (7) | (7) | $— | 2.9% |
| Other operating expenses, net | (7) | (14) | $7 | (50.0)% |
| Operating earnings | $155 | $102 | $53 | 51.7% |
| Interest expense | $(27) | $(49) | $22 | (44.9)% |
| Other, net | $(1) | $(4) | $3 | (75.0)% |
| Earnings before taxes | $127 | $49 | $78 | 158.6% |
| Income tax provision | $31 | $11 | $20 | 181.8% |
| Net earnings | $96 | $38 | $58 | 151.8% |
| Shares outstanding(1) | 145 | 145 | $— | —% |
| Basic EPS(1) | $0.66 | $0.26 | $0.40 | 151.8% |
| Diluted EPS(1) | $0.66 | $0.26 | $0.40 | 151.8% |
| Adjusted EPS(1,2) | $0.73 | $0.34 | $0.39 | 114.8% |
| Adjusted EBITDA(2) | $210 | $156 | $54 | 34.5% |
| Adjusted EBITDA Margin(2) | 10.2% | 8.0% | 2.2% | 27.6% |
| Backlog(2) | $3,152 | $3,454 | $(303) | (8.8)% |
| Bookings(2) | $1,919 | $2,542 | $(624) | (24.5)% |
| Free cash flow(2) | $(153) | $(267) | $114 | 42.6% |
NM- percentage change not meaningful
(1) Gives effect to a 1,450,000-for-1 forward stock split on our common stock effected on February 25, 2021.
(2) See “—Non-GAAP Financial Measures” above for definitions of these measures. Adjusted EPS, Adjusted EBITDA, Adjusted EBITDA Margin and free cash flow are non-GAAP measures. See “—Key Financial and Operating Measures—Non-GAAP Financial Measures” above for reconciliations of these measures to the most directly comparable financial measure calculated and presented in accordance with U.S. GAAP.
Our operating results for nine- months ended September 30, 2021 showed solid improvement from nine- months ended September 30, 2020. We generated revenue growth along with improved profitability generated from enhanced performance on development related programs coupled with an increase in our portion of revenue derived from full rate productions programs when compared to the prior nine month period ended September 30, 2020. Additionally, during the same period we reduced our cash usage over 42%. We also achieved a number of important program wins and performance milestones, all while maintaining our commitment to keep our employees as safe as possible and honoring our commitment to our service men and women.
Revenue of $2,059 million represented an organic increase of $107 million or 5.5% while operating earnings and net earnings grew $53 million (52%) and $58 million (152%) for the nine months ended September 30, 2021 when compared to the nine months ended September 30, 2020. Adjusted EBITDA increased by $54 million (35%) while adjusted EBITDA margins also increased by 270 bps to 10.2% for the nine months ended September 30, 2021 when compared to the nine months ended September 30, 2020.
Revenue
Our revenue of $720 million increased $1 million or 0.1% over the three months ended September 30, 2020 while our nine month revenue of $2,059 million increased $107 million or 5% over the nine months ended September 30, 2020. The revenue expansion for the nine months ended September 30, 2021 is attributed to continued growth within our AST and IMS segments. This growth is partially offset by our NC&C segment whose revenue contribution was slightly behind the prior year results. Our AST segment increased revenues by $75 million or 11% driven by increased sales of our ground vehicle sensing programs as well as the successful progress on our next generation soldier sensing programs. Additionally, our IMS segment revenues increased by $31 million or 6% as compared to the prior year period primarily due to increased production activity on our power and propulsion components of the CVN 80/81 multi-year aircraft carrier award received the prior year and on our counter unmanned aerial threat production program with the US Army.
Cost of Revenues
Cost of revenue for the three months ended September 30, 2021 decreased $8 million or 1% from $597 million to $589 million when compared to the three months ended September 30, 2020, despite the increased revenue output realized during the period. Cost of revenue for the nine months ended September 30, 2021 increased by $50 million or 3% from $1,615 million to $1,665 million primarily due to increased revenue as described above. Offsetting the volume based year over year cost of revenue growth is improved contract performance, decreasing the cost of revenues as a percentage of revenue highlighted by continued cost savings generated from our operational excellence program, APEX, and the continued transition of development programs into production. The program transition and improved profitability is highlighted by our soldier sensing within our AST segment and our submarine electric propulsion programs within our IMS sector.
Gross Profit
Gross profit increased by $9 million or 7.3% to $131 million for the third quarter and $57 million, or 17% to $394 million for the nine months ended September 30, 2021 as compared to $122 million and $337 million for the three and nine months ended September 30, 2020 respectively. This was primarily due to increased revenue and improved program performance as noted above.
General and Administrative Expenses
General and administrative expenses for the three months ended September 30, 2021 increased by $1 million or 1% as compared to the three months ended September 30, 2020 and increased by $11 million or 5% for the nine-months ended September 30, 2021 as compared to the nine months ended September 30, 2020. As a percentage of revenue, general and administrative expenses decreased to 10.93% for the nine months ended September 30, 2021 from 10.96% for the nine months ended September 30, 2020. The primary drivers for the increase in general and administrative expenses were related to additional internal research and development investments intended to maintain and expand our market position into the future. In total our IR&D expenditures increased $2 million and $5 million for the three and nine months ended September 30, 2021 as compared to the corresponding periods in the prior year. General and administrative expenses also increased due to costs required to operate as a public entity, including incremental accounting and audit fees as well as the recent expansion of our Board of Directors. Lastly, we incurred an incremental $4 million of transaction costs related to an anticipated offering of securities for the nine months ended September 30, 2021.
Other Operating Expenses, Net
Other operating expenses decreased by $8 million to $2 million in the three months ended September 30, 2021 when compared to $10 million for the three months ended September 30, 2020. For the nine months ended September 30, 2021 other operating expenses decreased by $7 million from $14 million for nine months ended September 30, 2020 to $7 million for nine months ended September 30, 2021. This decrease is primarily due to lower employee safety costs related to COVID-19.
Amortization of Intangibles
Amortization of intangibles of $3 million and $7 million for three and nine months ended September 30, 2021 were consistent with three and nine months ended September 30, 2020.
Operating Earnings
Operating earnings increased by $16 million and $53 million to $53 million and $155 million for three and nine months ended September 30, 2021 from $37 and $102 million for the three and nine months ended September 30, 2020. The increase was driven by a combination of increased revenue and improved program performance offset in part by increased general and administrative expenditures.
Interest Expense
Interest expense decreased in both the three and nine months ended September 30, 2021 by $8 million and $22 million respectively. This represented a 45% decrease to $27 million for the nine months ended September 30, 2021 from the prior year $49 million of interest expenditures realized for the nine months ended September 30, 2020. The reduction was primarily due to forgiveness of $300 million of principal on our 7.5% Term Loan debt that occurred in December of 2020 and a decrease in both the overall borrowing levels and rate on our variable rate revolving credit facility.
Other, Net
Other, net decreased for the nine months ended September 30, 2021 to $1 million from $4 million for the nine months ended September 30, 2020. This was primarily due to a reduction in foreign exchange and Pension related charges realized during the period. In the nine months ended September 30, 2020 our IMS segment realized a foreign exchange loss related to revaluation of certain Canadian dollar denominated receivables.
Earnings Before Taxes
Earnings before taxes increased by $24 million and $78 million to $43 million and $127 million for the three and nine months ended September 30, 2021, respectively, from $19 million and $49 million for the three and nine months ended September 30, 2020. The improved profitability resulted in a 159% increase in earnings before taxes for the nine months ended September 30, 2021 as compared to the prior year period. The increase was primarily due to an increase in operating earnings generated from increased revenue volume, improved program performance and a reduction in interest expense generated from the reduced debt obligations outstanding.
Income Tax Provision
Income tax provision increased by $4 million and $20 million to $8 million and $31 million for the three-and nine- months ended September 30, 2021, respectively, from $4 million and $11 million for the three-and nine- months ended September 30, 2020. This was primarily attributable to an increase in earnings before taxes of $24 million and $78 million for the third quarter and nine months ended September 30, 2021, respectively, as well as an increase in our estimated annual effective tax rate due to certain state law tax changes and an increase in estimated nondeductible expenses driven by expenditures in connection with a potential initial public offering as compared to the prior year.
Net Earnings
Net earnings increased by $20 million and $58 million to $35 million and $96 million for the three-and nine- months ended September 30, 2021, respectively, when compared to the three-and nine- months ended September 30, 2020. This was driven by increased earnings before taxes of $78 million offset by increased in income tax provision of $20 million as described above.
Basic and Diluted EPS
For the three and nine months ended September 30, 2021 there were no changes in the number of basic and diluted shares. No equity awards were issued during the three- and nine- month periods. As of September 30, 2021 and September 30, 2020 there were 145,000,000 shares of common stock outstanding, resulting in a basic and diluted EPS of $0.66 and $0.26 per share, respectively. The increase in EPS is attributed to the net earnings growth described above.
Adjusted EBITDA
Adjusted EBITDA increased by $9 million or 15% to $71 million for the three months ended September 30, 2021 and $54 million or 35% to $210 million for the nine months ended September 30, 2021 when compared to $61 million and $156 million for the three-and nine-months ended September 30, 2020, respectively. This was primarily due to the increase in gross profit attributed to revenue growth as described above and increased program performance across all three segments offset slightly by an increase in General & Administrative expenses.
Adjusted EBITDA Margin
Adjusted EBITDA Margin increased from 8.5% for the three months ended September 30, 2020 to 9.8% for the three months ended September 30, 2021 and from 8.0% for the nine months ended September 30, 2020 to 10.2% for the nine months ended September 30, 2021. This was primarily due to improved program performance and the transition of certain development programs into production driving margin expansion.
Adjusted EPS
For the three- and nine- month periods ended September 30, 2021 there were no changes in the number of basic and diluted shares. No equity awards were issued during the period. As of September 30, 2021 there were 145,000,000 shares of common stock outstanding resulting in Adjusted EPS of $0.73. This increase of $0.39 from $0.34 for the nine months ended September 30, 2020 is attributed to the net earnings growth described above.
Backlog
Backlog decreased by $303 million to $3,152 million for the nine months ended September 30, 2021 from $3,454 million for the nine months ended September 30, 2020. The decrease is primarily attributable to the continued production work on significant contract awards received in the nine months ended September 30, 2020, including the multi-carrier power conversion award for our CVN80/81 platform, multi-year solider sensing programs received at our AST segment, and continued production work on active protection program in our IMS segment. These decreases were partially offset by awards for short range air defense programs awarded in the nine months ended September 30, 2021.
Bookings
We review bookings and backlog measures together when comparing current and prior periods as timing of incrementally funded contracts can vary based on customers’ authorization levels. These funding increments together with the duration of contracts received may create large fluctuations in bookings period over period and, therefore, we review bookings in conjunction with backlog trends. In line with the decreased backlog position described under “--Backlog” above, bookings for the nine month ended September 30, 2021 decreased by 25% or $624 million to $1,919 million as compared to $2,542 million for the nine month ended September 30, 2020. The decrease is attributable to all three segments due primarily to significant programs awarded in the first nine months of 2020. In the first nine months of 2020 our AST segment received multi-year full rate production awards in our soldier sensing and airborne force protection markets fueling the increased profitability noted above and our IMS segment received a multi-ship set award for power conversion for the CVN80/81 platform.
Free cash flow
Free cash flow improved by $114 million to $(153) million for the nine months ended September 30, 2021 from $(267) million for the nine months ended September 30, 2020. This was primarily due to the impact of higher net income as stated above of $19 million (excluding non cash items) and decrease in cash used to fund working capital for the nine months ended September 30, 2021 as compared to nine months ended September 30, 2020.
Review of Operating Segments
The following is a discussion of operating results for each of our operating segments. We have elected to use Revenue, Adjusted EBITDA, Adjusted EBITDA Margin, and Bookings to provide detailed information on our segment performance. Additional information regarding our segments can be found in Note 15: Segment information within the unaudited Consolidated Financial Statements.
(Dollars in millions)
| Revenue: | Three Months Ended September 30, 2021 2021 | 2020 | Three Months Ended September 30, 2021 vs. September 30, 2020 Variance $% | |
|---|---|---|---|---|
| AST | $279 | $263 | $17 | 6.3% |
| NC&C | $239 | $267 | $(28) | (10.5%) |
| IMS | $209 | $194 | $16 | 8.1% |
| Corporate & Eliminations | $(7) | $(4) | $(3) | 80.0% |
| Total revenue | $720 | $719 | $1 | 0.1% |
| Adjusted EBITDA: | ||||
| AST | $34 | $38 | $(4) | (11.3%) |
| NC&C | $22 | $19 | $3 | 18.3% |
| IMS | $14 | $3 | $11 | (396.4%) |
| Corporate & Eliminations | $— | $2 | $(2) | (105.0%) |
| Total Adjusted EBITDA | $70 | $61 | $8 | 13.2% |
| Adjusted EBITDA Margin: | ||||
| AST | 12.1% | 14.5% | (2.4%) | (16.6%) |
| NC&C | 9.2% | 7.0% | 2.2% | 32.1% |
| IMS | 6.6% | 1.4% | 5.2% | (359.1%) |
| Bookings: | ||||
| AST | $184 | $206 | $(22) | (10.5%) |
| NC&C | $202 | $218 | $(16) | (7.4%) |
| IMS | $99 | $527 | $(428) | (81.3%) |
| Total bookings | $485 | $951 | $(466) | (49.0%) |
43
(Dollars in millions)
| Revenue: | Nine Months Ended September 30, 2021 | 2020 | Nine Months Ended September 30, 2021 vs. September 30, 2020 Variance $% | |
|---|---|---|---|---|
| AST | $743 | $668 | $75 | 11.3% |
| NC&C | $747 | $749 | $(2) | (0.3%) |
| IMS | $584 | $553 | $31 | 5.6% |
| Corporate & Eliminations | $(15) | $(18) | $3 | (14.5%) |
| Total revenue | $2,059 | $1,952 | $107 | 5.5% |
| Adjusted EBITDA: | ||||
| AST | $99 | $80 | $19 | 23.4% |
| NC&C | $72 | $60 | $12 | 20.0% |
| IMS | $39 | $15 | $24 | 168.3% |
| Corporate & Eliminations | $— | $2 | $(2) | (105.0%) |
| Total Adjusted EBITDA | $210 | $157 | $53 | 33.9% |
| Adjusted EBITDA Margin: | ||||
| AST | 13.3% | 12.0% | 1.3% | 10.9% |
| NC&C | 9.6% | 8.0% | 1.6% | 20.3% |
| IMS | 6.7% | 2.6% | 4.0% | 154.0% |
| Bookings: | ||||
| AST | $604 | $715 | $(112) | (15.6%) |
| NC&C | $755 | $974 | $(219) | (22.5%) |
| IMS | $560 | $853 | $(293) | (34.4%) |
| Total bookings | $1,919 | $2,542 | $(623) | (24.5%) |
AST
Revenue:
The AST segment continued to be a significant contributor to revenue growth with three months ended September 30, 2021 increasing by 6.3% or $17 million to $279 million from $263 million for three months ended September 30, 2020. The AST contribution to revenue for the nine months ended September 30, 2021 was also strong resulting in an increase in revenue by 11.3% or $75 million to $743 million from $668 million for the nine months ended September 30, 2020. This increase is primarily attributed to the transition to production and increased deliveries on our next generation soldier sensing programs, including our weapon sights and targeting systems coupled with continued upgrades of our existing ground vehicle sensing programs. Additionally revenues realized on our recently awarded Navy shipboard launch system component program also contributed to the revenue expansion as compared to the prior period.
Adjusted EBITDA and Adjusted EBITDA Margin:
AST’s Adjusted EBITDA decreased by $4 million or 11%, from $38 million for three months ended September 30, 2020 to $34 million for three months ended September 30, 2021. Despite the decrease in quarterly Adjusted EBITDA, Adjusted EBITDA for the nine months ended September 30, 2021 increased by $19 million or 23% from $80 million for the nine months ended September 30, 2020 to $99 million for the nine months ended September 30, 2021. The quarterly decrease in Adjusted EBITDA resulted in a corresponding decrease in our Adjusted EBITDA Margin from 14% to 12% for the three months ended September 30, 2020 as compared to the three months ended September 30, 2021. Similarly, the increase in Adjusted EBITDA as compared to the the nine months ended September 30, 2020 resulted in a corresponding increase in Adjusted EBITDA Margin from 12% to 13% for the nine months end September 30, 2020 as compared to the nine months ended September 30, 2021. The increase in Adjusted EBITDA and Adjusted EBITDA Margin is primarily due to revenue mix highlighted by the development to production transition on our soldier sensing programs, coupled with improved performance on legacy ground vehicle sensing and certain electronic warfare programs, coupled with an overall increase in revenue volume creating increased operational leverage for the segment. This increase in overall profitability was offset in part by increased investment in internal research and development related expenditures.
Bookings:
The AST segment contributed $184 million and $604 million in new bookings for three and nine months ended September 30, 2021, respectively. Bookings were down for both the three and nine months ended September 30, 2021, by 10% or $22 million and 16% or $112 million as compared to the three and nine months ended September 30, 2020. This was primarily due to the receipt of multi-year full year production awards for our next generation weapon sight and certain aircraft force protection programs received during the three and nine months ended September 30, 2020.
NC&C
Revenue:
NC&C revenue decreased by $28 million or 10% to $239 million for the three months ended September 30, 2021 from $267 million for the three months ended September 30, 2020. Although more favorable than the quarterly results, NC&C revenue decreased $2 million or 0.3% to $747 million for the nine months ended September 30, 2021. The decrease was driven by program transition to the next award on our submarine computing upgrade program with the US Navy and lower revenue on certain “off the shelf” naval electronics programs that were dilutive to our overall margin profile. This was offset in part by our continued market penetration realized on our ground vehicle ruggedized computing programs.
Adjusted EBITDA and Adjusted EBITDA Margin:
NC&C’s Adjusted EBITDA increased by $3 million, or 18.3%, from $19 million for three months ended September 30, 2020 to $22 million for three months ended September 30, 2021. Adjusted EBITDA increased by $12 million or 20% from $60 million for the nine month ended September 30, 2020 to $72 million for the nine month ended September 30, 2021. Adjusted EBITDA Margin increased from 7% for the three months ended September 30, 2020 to 9% for three months ended September 30, 2021, and from 8% to 10% for the nine months ended September 30, 2020 as compared to the nine months ended September 30, 2021 respectively. The increase in Adjusted EBITDA for the nine months ended September 30, 2020 is primarily due to improved program performance across our naval computing program portfolio resulting from our APEX efficiency program, driving margin expansion.
Bookings:
The NC&C segment contributed $202 million and $755 million in new bookings for three and nine months ended September 30, 2021, respectively. Bookings decreased for both the three and nine months ended September 30, 2021 by 7% or $16 million and 22% or $219 million as compared to the three and nine months ended September 30, 2020. This decrease was primarily due to prior year multi-year awards received on our ruggedized computing and diagnostic programs with the US Army and our common display systems award with the US Navy.
IMS
Revenue:
IMS segment revenue increased by $16 million or 8% to $209 million for the three months ended September 30, 2021 from $194 million for the three months ended September 30, 2020. Overall, IMS revenue increased for the nine months ended September 30, 2021 by $31 million or 6% to $584 million from $553 million for the nine months ended September 30, 2020. This increase was primarily due to increased progress on our force protection programs highlighted by the newly awarded short range air defense programs as well as continued production efforts on the power conversion components on the CVN 80/81 contract award.
Adjusted EBITDA and Adjusted EBITDA Margin:
IMS’s Adjusted EBITDA increased by $11 million or 396% to $14 million for three months ended September 30, 2021 from $3 million for the three months ended September 30, 2020 with the trend continuing for the nine months ended September 30, 2021. Adjusted EBITDA increased by $24 million or 168% from $15 million for the nine month ended September 30, 2020 to $39 million for the nine months ended September 30, 2021. Adjusted EBITDA Margin increased from 1% for the three months ended September 30, 2020 to 7% for three months ended September 30, 2021. Adjusted EBITDA continued to drive increases in Adjusted EBITDA Margins from 3% to 7% for the nine months ended September 30, 2020 to the nine months ended September 30, 2021 respectively. The increased profitability is primarily due to improved performance on key design programs including our submarine electric propulsion programs, increased revenue and related operational leverage generated by progress on force protection programs noted above and continued program performance improvements as our development programs transition to production.
Bookings:
The IMS segment contributed $99 million and $560 million in new bookings for three and nine months ended September 30, 2021 respectively. Bookings decreased for both the three and nine months ended September 30, 2021 by 81% or $428 million and 34% or $293 million as compared to the three and nine months ended September 30, 2020. This decrease was primarily due to our IMS segment receiving a multi ship set award for power conversion components on the CVN80/81 platform in the three and nine months ended September 30, 2020.
Liquidity and Capital Resources
We endeavor to ensure the most efficient conversion of operating income into cash for deployment in our business and to maximize shareholder value through cash deployment activities. In addition to our cash position, we use various financial measures to assist in capital deployment decision-making, including cash provided by operating activities and free cash flow, a non-GAAP measure described in more detail below. We believe that the combination of our existing cash, access to credit facilities as described in Note 10: Debt and future cash that we expect to generate from our operations will be sufficient to meet our short and long-term liquidity needs. There can be no assurance, however, that our business will continue to generate cash flow at current levels or that anticipated operational improvements will be achieved. We may also pursue acquisitions or other strategic priorities that will require additional liquidity beyond the liquidity we generate through our operations. Our cash balance as of September 30, 2021, was $78 million compared to $61 million as of December 31, 2020.
The following table summarizes our cash flows for the periods presented:
(Dollars in millions)
| Nine Months Ended September 30, 2021 | 2020 | |
|---|---|---|
| Net cash used in operating activities | $(111) | $(230) |
| Net cash provided by investing activities | 58 | 62 |
| Net cash provided by financing activities | 70 | 181 |
| Effect of exchange rate changes on cash and cash equivalents | — | (1) |
| Net increase in cash and cash equivalents | $17 | $12 |
| Free cash flow(1) | $(153) | $(267) |
(1) Free cash flow is a Non-GAAP measure. The reasons we use this Non-GAAP financial measure and its reconciliation to the most directly comparable U.S. GAAP financial measure is provided above under “—Key Financial and Operating Measures—Non-GAAP Financial Measures.”
Operating Activities
Cash flows related to the operating activities improved by $119 million, reducing cash usage from $(230) million for the nine months ended September 30, 2020 to $(111) million for the nine months ended September 30, 2021. This was primarily due to higher net income as described above excluding non-cash items and a decrease in cash used to fund working capital for the nine months ended September 30, 2021 when compared to nine month ended September 30, 2020.
Investing Activities
Net cash provided by investing activities decreased by $4 million for the nine months ended September 30, 2021 as compared to the nine months ended September 30, 2020. The decrease was primarily attributable to the investment in AES and increased capital expenditures offset by an increase of $15 million in the amount of the advance being repaid by US Holding.
Financing Activities
Net cash provided by financing activities decreased by $(111) million for the nine months ended September 30, 2021 versus September 30, 2020. The decrease was primarily related to a decrease in the net borrowings under our revolving credit facility due to improvements in profitability and working capital management as compared to the nine months ended September 30, 2020.
Free Cash Flow
Free cash flow increased by $114 million to $(153) million for nine months ended September 30, 2021 from $(267) million for the nine months ended September 30, 2020. This was primarily due to the impact of higher net income as stated above of $20 million (excluding non cash items) and decrease in cash used to fund working capital for the nine months ended September 30, 2021 when compared to three months ended September 30, 2020.
Market risk
As filed, 2,116 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Equity Risk
We currently have limited risk related to fluctuations in marketable securities. Outside of pension assets which are disclosed in Note 11: Pension and Other Postretirement Benefits to the Consolidated Financial Statements, the only investments the Company holds are overnight money market accounts. Fluctuations are unlikely and would have limited impact on the financial statements of the Company.
Interest Rate Risk
We are exposed to interest rate risk on variable-rate borrowings under our revolving credit facilities, which had an outstanding balance of $75 million as of September 30, 2021. Our remaining debt facilities are fixed rate obligations and not subject to fluctuations in interest rates. For additional information please refer to Note 10. Debt .
Foreign Currency Risk
In certain circumstances, we may be exposed to foreign currency risk. However, as the overwhelming majority of our revenue is derived from U.S. sources directly as a prime contractor or indirectly as a subcontractor for the U.S. government as end-customer, we have limited foreign currency exposure. Currently our exposure is primarily with the Canadian dollar and limited to receivables owed of $33 million as of September 30, 2021. A 10% fluctuation in exchange rates would not have a material impact on our financial statements. We do not enter into or issue derivative instruments for trading purposes.
Inflation Risk
We have generally been able to anticipate increases in costs when pricing our contracts. Bids for longer-term firm fixed-price contracts typically include assumptions for labor and other cost escalations in amounts that historically have been sufficient to cover cost increases over the period of performance, however material changes in supplier pricing may have significant impacts in our ability to achieve our estimates to complete certain programs and thus our profitability levels. Please see “Risk Factors” in our registration statement on Form S-1, as amended (Registration No. 333-253583), which was declared effective by the SEC on March 23, 2021, for further details.
Controls and procedures
As filed, 1,499 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the nine-month period ended September 30, 2021, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our principal executive officer and principal financial officer has concluded that during the period covered by this report, our disclosure controls and procedures were effective.
Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
Changes in Internal Control over Financial Reporting
There was no change in our internal control over financial reporting that occurred during the three-month period ended September 30, 2021 covered by this Quarterly Report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Risk factors
As filed, 2,219 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Other than set forth below, there have been no material changes to the risk factors disclosed in our Form S-1, as amended (Registration No. 333-253583), which was declared effective by the SEC on March 23, 2021.
The COVID-19 pandemic and related impacts have had and are likely to continue to have an adverse impact on our business, financial condition and results of operations.
We are continuing to closely monitor COVID-related impacts on all aspects of our business and geographies, including on our workforce, supply chain and customers. On September 9, 2021, President Biden announced a COVID-19 action plan, including an executive order, the Safer Workforce Task Force guidance issued on September 24, 2021 and the DoD’s Force Health Protection guidance. This executive order and guidance (as amended) requires U.S. based federal contractors’ employees to have had their final vaccination dose by January 4, 2022, with exceptions including where an employee is legally entitled to an accommodation. Although we are taking steps to comply with the executive order, guidance and related contractual terms required by our customers, these mandates could materially and adversely affect our financial condition, results of operations, cash flows and equity, including through employee attrition for us or our subcontractors.
State and local governments are also continuing to take actions related to the pandemic, imposing additional and varying requirements on our industry. We are continuing to evaluate these evolving requirements, especially as our customers determine when and how to implement new contractual requirements. We cannot at this stage predict the various impacts they may have on our workforce, our suppliers, or our company. These evolving government requirements, including regarding a vaccine mandate, along with broader impacts of the continuing pandemic, could impact our workforce and performance, as well as those of our suppliers. All of these factors remain highly uncertain and unpredictable and could exacerbate other risks discussed in Item 1A. “Risk Factors” of our Form S-1, as amended (Registration No. 333-253583), which was declared effective by the SEC on March 23, 2021.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2021-07-01 to 2021-09-30 | $720.0m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2021-01-01 to 2021-09-30 | $2.06bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2021-07-01 to 2021-09-30 | $589.0m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2021-01-01 to 2021-09-30 | $1.67bn | us-gaap:CostOfRevenue |
| Gross profit | 3 months2021-07-01 to 2021-09-30 | $131.0m | us-gaap:GrossProfit |
| Gross profit | 9 months2021-01-01 to 2021-09-30 | $394.0m | us-gaap:GrossProfit |
| Operating income | 3 months2021-07-01 to 2021-09-30 | $53.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2021-01-01 to 2021-09-30 | $155.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2021-07-01 to 2021-09-30 | $9.0m | us-gaap:InterestExpense |
| Interest expense | 9 months2021-01-01 to 2021-09-30 | $27.0m | us-gaap:InterestExpense |
| Income tax | 3 months2021-07-01 to 2021-09-30 | $8.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2021-01-01 to 2021-09-30 | $31.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2021-07-01 to 2021-09-30 | $35.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2021-01-01 to 2021-09-30 | $96.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2021-07-01 to 2021-09-30 | $0.24 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2021-01-01 to 2021-09-30 | $0.66 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2021-07-01 to 2021-09-30 | $0.24 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2021-01-01 to 2021-09-30 | $0.66 | us-gaap:EarningsPerShareBasic |
| Operating cash flow | 9 months2021-01-01 to 2021-09-30 | −$111.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2021-01-01 to 2021-09-30 | $42.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2021-09-30 | $78.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-09-30 | $1.23bn | us-gaap:AssetsCurrent |
| Total assets | At period end2021-09-30 | $2.89bn | us-gaap:Assets |
| Current liabilities | At period end2021-09-30 | $832.0m | us-gaap:LiabilitiesCurrent |
| Current portion of debt | At period end2021-09-30 | $124.0m | us-gaap:DebtCurrent |
| Short-term borrowings | At period end2021-09-30 | $24.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2021-09-30 | $1.53bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001628280-21-023021. Last ingested by Listed: Nov 14, 2026, 21:34 ET. Listed shows no prices and gives no investment advice.